These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20708557)

  • 1. Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents.
    Skinner SR; Cooper Robbins SC
    J Adolesc Health; 2010 Sep; 47(3):215-8. PubMed ID: 20708557
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccine and adolescents.
    Dempsey AF; Zimet GD
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):447-54. PubMed ID: 18797267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.
    Sinka K; Kavanagh K; Gordon R; Love J; Potts A; Donaghy M; Robertson C
    J Epidemiol Community Health; 2014 Jan; 68(1):57-63. PubMed ID: 23986492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lessons learned from extramural school programs that offer HPV vaccine.
    Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT
    J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience.
    Robbins SC; Bernard D; McCaffery K; Skinner SR
    Sex Health; 2010 Sep; 7(3):271-8. PubMed ID: 20719214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with completion of the human papillomavirus vaccine series.
    Neubrand TP; Breitkopf CR; Rupp R; Breitkopf D; Rosenthal SL
    Clin Pediatr (Phila); 2009 Nov; 48(9):966-9. PubMed ID: 19483128
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.
    Jeannot E; Petignat P; Sudre P
    Public Health Rep; 2015; 130(3):202-6. PubMed ID: 25931623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
    Porta M; González B; Márquez S; Artazcoz L
    J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF; Freed GL
    J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
    [No Abstract]   [Full Text] [Related]  

  • 12. Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches.
    Rouzier R; Giordanella JP
    J Adolesc Health; 2010 Sep; 47(3):237-41. PubMed ID: 20708561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practice model for immunization: one home care agency's experience providing H1N1 and seasonal vaccine.
    Rolfe E; Howard LA
    Home Healthc Nurse; 2010 Oct; 28(9):524-32. PubMed ID: 20881796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 16. Ill-informed consent? A content analysis of physical risk disclosure in school-based HPV vaccine programs.
    Steenbeek A; Macdonald N; Downie J; Appleton M; Baylis F
    Public Health Nurs; 2012; 29(1):71-9. PubMed ID: 22211754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccinations, fall 2009: model school-located vaccination clinics.
    Jenlink CH; Kuehnert P; Mazyck D
    J Sch Nurs; 2010 Aug; 26(4 Suppl):7S-13S. PubMed ID: 20418493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey.
    Kudjawu Y; Lévy-Bruhl D; Celentano LP; O'Flanagan D; Salmaso S; Lopalco P; Mullins N; Bacci S;
    Euro Surveill; 2007 Apr; 12(4):E070426.1. PubMed ID: 17868608
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of volunteers to conduct school-located mass influenza vaccination clinics.
    Cummings GE; Ruff E; Guthrie SH; Hoffmaster MA; Leitch LL; King JC
    Pediatrics; 2012 Mar; 129 Suppl 2():S88-95. PubMed ID: 22383487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.